These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. The comparative prophylactic efficacy of lithium and carbamazepine in patients with bipolar I disorder. Greil W; Kleindienst N Int Clin Psychopharmacol; 1999 Sep; 14(5):277-81. PubMed ID: 10529070 [TBL] [Abstract][Full Text] [Related]
6. Carbamazepine in the prophylaxis of major depression: a 5-year follow-up. Stuppaeck CH; Barnas C; Schwitzer J; Fleischhacker WW J Clin Psychiatry; 1994 Apr; 55(4):146-50. PubMed ID: 8071258 [TBL] [Abstract][Full Text] [Related]
7. Rational polypharmacy in the bipolar affective disorders. Post RM; Ketter TA; Pazzaglia PJ; Denicoff K; George MS; Callahan A; Leverich G; Frye M Epilepsy Res Suppl; 1996; 11():153-80. PubMed ID: 9294735 [TBL] [Abstract][Full Text] [Related]
8. Prophylaxis of schizoaffective disorder with lithium or carbamazepine: outcome after long-term follow-up. Baethge C; Gruschka P; Berghöfer A; Bauer M; Müller-Oerlinghausen B; Bschor T; Smolka MN J Affect Disord; 2004 Apr; 79(1-3):43-50. PubMed ID: 15023479 [TBL] [Abstract][Full Text] [Related]
9. Lithium versus carbamazepine in the maintenance treatment of bipolar II disorder and bipolar disorder not otherwise specified. Greil W; Kleindienst N Int Clin Psychopharmacol; 1999 Sep; 14(5):283-5. PubMed ID: 10529071 [TBL] [Abstract][Full Text] [Related]
10. Lithium therapy for unipolar and bipolar depression among the middle-aged and older adult patient subpopulation. Lepkifker E; Iancu I; Horesh N; Strous RD; Kotler M Depress Anxiety; 2007; 24(8):571-6. PubMed ID: 17133442 [TBL] [Abstract][Full Text] [Related]
11. Aggressive behavior in Huntington's disease: treatment with propranolol. Stewart JT; Mounts ML; Clark RL J Clin Psychiatry; 1987 Mar; 48(3):106-8. PubMed ID: 2880838 [TBL] [Abstract][Full Text] [Related]
12. Serotonin transporter gene and response to lithium augmentation in depression. Stamm TJ; Adli M; Kirchheiner J; Smolka MN; Kaiser R; Tremblay PB; Bauer M Psychiatr Genet; 2008 Apr; 18(2):92-7. PubMed ID: 18349701 [TBL] [Abstract][Full Text] [Related]
13. [Value of fluoxetine in obsessive-compulsive disorder in the adult: review of the literature]. Etain B; Bonnet-Perrin E Encephale; 2001; 27(3):280-9. PubMed ID: 11488259 [TBL] [Abstract][Full Text] [Related]
14. Effectiveness of fluoxetine and doxepin in treatment of melancholia in depressed patients. Sandor P; Baker B; Irvine J; Dorian P; McKessok D; Mendlowitz S Depress Anxiety; 1998; 7(2):69-72. PubMed ID: 9614594 [TBL] [Abstract][Full Text] [Related]
15. Comparative effectiveness of carbamazepine and propranolol for rage outbursts. Mattes JA J Neuropsychiatry Clin Neurosci; 1990; 2(2):159-64. PubMed ID: 2136070 [TBL] [Abstract][Full Text] [Related]
16. The manic syndrome: factors which may predict a patient's response to lithium, carbamazepine and valproate. Dilsaver SC; Swann AC; Shoaib AM; Bowers TC J Psychiatry Neurosci; 1993 Mar; 18(2):61-6. PubMed ID: 8461283 [TBL] [Abstract][Full Text] [Related]
17. Fluoxetine in the treatment of depression in Asian (Chinese and Indian) patients in Singapore. Tsoi WF; Tan CT; Kok LP Singapore Med J; 1995 Aug; 36(4):397-9. PubMed ID: 8919155 [TBL] [Abstract][Full Text] [Related]
19. Self-injurious behavior and serotonin in Prader-Willi syndrome. Hellings JA; Warnock JK Psychopharmacol Bull; 1994; 30(2):245-50. PubMed ID: 7831463 [TBL] [Abstract][Full Text] [Related]
20. An update on the use of lithium carbonate in aggressive children and adolescents with conduct disorder. Campbell M; Kafantaris V; Cueva JE Psychopharmacol Bull; 1995; 31(1):93-102. PubMed ID: 7675995 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]